Applications of pharmacogenetics in psychiatry: Personalisation of treatment

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 4, 2001, Pages 537-542

  Arranz, M J ^a   Munro, J ^a   Osborne, S ^a   Collier, D ^a   Kerwin, R W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antipsychotic response; Clozapine; Olanzapine; Pharmacogenetics; Response prediction

Indexed keywords

CLOZAPINE; CYTOCHROME P450 ISOENZYME; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; FLUVOXAMINE; HLA ANTIGEN; NEUROLEPTIC AGENT; NEUROTRANSMITTER RECEPTOR; OLANZAPINE; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TUMOR NECROSIS FACTOR; CYP2C9 PROTEIN, HUMAN; CYTOCHROME P 450 CYP2D6; CYTOCHROME P450 2D6; UNSPECIFIC MONOOXYGENASE;

AGRANULOCYTOSIS; AKATHISIA; DRUG EFFICACY; DRUG METABOLISM; DRUG RESPONSE; DRUG TARGETING; FEASIBILITY STUDY; GENETIC POLYMORPHISM; HUMAN; INDIVIDUALIZATION; PATIENT CODING; PHARMACOGENETICS; PREDICTION; PROMOTER REGION; PSYCHIATRY; REVIEW; SCHIZOPHRENIA; TARDIVE DYSKINESIA; GENETIC VARIABILITY; GENETICS; GENOME; MENTAL DISEASE;

ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP2D6; GENOME, HUMAN; HUMAN; MENTAL DISORDERS; PHARMACOGENETICS; RECEPTORS, NEUROTRANSMITTER; VARIATION (GENETICS);

EID: 0035023510     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2.4.537     Document Type: Review

References (38)

1. Neuroleptics and the natural course of schizophrenia
2. Neurotransmitter-related genes and antipsychotic response: Pharmacogenetics meets psychiatric treatment
3. 2A receptors and clozapine response
4. Extreme discordant phenotype methodology: An intuitive approach to clinical pharmacogenetics
5. Pharmacogenetics and psychopharmacotherapy
6. Molecular mechanisms of genetic polymorphisms of drug metabolism
7. Polymorphic cytochromes P450 and drugs used in psychiatry
8. Catalytic activity of three variants (Ile, Leu and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysis
9. Rapid and comprehensive determination of cytochrome P450CYP2D6 poor metabolizer genotypes by multiplex polymerase chain reaction
10. Pharmacogenomics and schizophrenia
11. Association between clozapine response and allelic variation in the 5-HT2A receptor gene
12. Association between clozapine response and allelic variation in the 5-HT2C receptor gene
13. Replication and meta-analysis of alleleic association of a 5-HT2C receptor polymorphism with good response to clozapine
14. Polymorphisms in dopamine receptors: What do they tell us?
15. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
16. Serotonin transporter gene polymorphism and antidepressant response
17. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response
18. 3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients
19. 3 receptor gene with tardive dyskinesia in schizophrenia
20. 3 receptor and tardive dyskinesia in chronic schizophrenia
21. 3-receptro gene variants with neuroleptic induced akathisia in schizophrenic patients: A generalization of Steen's study on DRD3 and tardive dyskinesia
22. 3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients
23. A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: Association with tardive dyskinesia in schizophrenia
24. HLA associations in clozapine-induced agranulocytosis
25. Tumor necrosis factor constellation polymorphism and clozapin-induced agranulocytosis in two different ethnic groups
26. An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201
27. HLA-B38 and clozapine-induced agranulotycosis in Israeli Jewish schizophrenic patients
28. Pharmacogenetic prediction of clozapine response
29. Influence of polymorphisms in serotonin receptors on response to atypical antipsychotics
30. The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation
31. A new genetic defect in human CYP2C19: Mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin
32. Polymorphic drug oxidation-Relevance to the treatment of psychiatric disorders
33. Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene
34. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: Characterization of 48 mutations and 53 alleles, their frequencies and evolution
35. 4 receptor gene polymorphisms and neuroleptic response in schizophrenia
36. Polymorphisms of the dopamine D-4 receptor and response to antipsychotic drugs
37. 2A receptor and clinical response to clozapine